Bullboard - Stock Discussion Forum Allakos Inc ALLK

Healthcare Biotechnology

Allakos Inc. is a clinical-stage biotechnology company, which is engaged in the development of therapeutics that target immunomodulatory receptors present on immune effector cells involved in allergy, inflammatory and proliferative diseases. The Company’s most advanced product candidate, AK006, is in a Phase I clinical trial. AK006 targets Siglec-6, an inhibitory receptor expressed selectively... see more

Add To Watchlist

NDAQ:ALLK - Post Discussion

Allakos Inc > SHOULD ALLAKOS INC BE ON YOUR INVESTMENT WATCHLIST?

View:

Post by AviseAnalytics on Jan 10, 2022 7:47am

SHOULD ALLAKOS INC BE ON YOUR INVESTMENT WATCHLIST?

$ALLK

Allakos Inc. (NASDAQ:ALLK), a clinical-stage biopharmaceutical company developing therapeutic monoclonal antibodies for treatment of inflammatory, and proliferative diseases, faced a setback with disappointing results from a crucial phase 3 trial named Enigma 2 and phase 2/3 Kryptos trial.

Should you invest in the Company or watch from the sidelines?

Read on to find out more!

https://www.aviseanalytics.com/should-allakos-inc-be-on-your-investment-watchlist/

235